The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) | MicrobiomeTrials← Back to trialsNCT04207944
The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2020-07-10Est. Completion: 2026-07-30
Enrollment target: 100 participants Locations- Johns Hopkins University, Baltimore, Maryland, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Memorial Sloan Kettering, New York, New York, United States
- Duke University Medical Center, Durham, North Carolina, United States
Other microbiome trials you might be interested in
IPMN, PancreaticPancreatic Cancer, ResectedPancreatic Cancer BorderlineChronic Pancreatitis
Pancreatic surgery is the only treatment in the multimodality approach to pancreatic cancer sine qua non long-term survi…
Leiden, NetherlandsEst. completion Dec 31, 2027
Pancreatic Cancer, Adult
The investigators' goal is to conduct a prospective multicenter study to evaluate the yield and outcomes of screening of…
Boston, United StatesEst. completion Dec 31, 2032